Biocon

Biocon Biologics, an arm of biotechnology major Biocon, on Thursday said clinical study for its biologic drug Itolizumab for possible indication in autoimmune disease Lupus Nephritis has been initiated in India after approval from the Drugs C

Biocon will seek to hold a controlling majority stake in the merged entity and the companies will also look for an initial public offering (IPO).

Foreign institutional investors sold shares worth Rs 561 crore on Tuesday while domestic institutional investors bought shares worth Rs 577 crore.

The domestic stock markets are expected to trade in red on Wednesday, taking cues from the global markets.

Kiran Mazumdar-Shaw on Monday said media reports on the ''Pandora Papers'' leak have wrongly implicated her husband's offshore trust

Biocon Biologics will offer approximately 15 per cent stake to SILS, at a valuation of $4.9 billion.

Finance Minister Nirmala Sitharaman announced the formation of a 'bad bank', with the government guaranteeing up to Rs 30,600 crore for security receipts issued by the National Asset Reconstruction Company

A commentary on the website of the medical journal The Lancet authored by 21 people including Biocon's Kiran Mazumdar Shaw and top surgeon Dr Devi Shetty has recommended eight actions to prepare for a possible resurgence of COVID-19 cases in India.

The ongoing COVID-19 public health crisis has resulted in the creation of an "ecosystem" of innovation in India, Biocon chief Kiran Mazumdar-Shaw has said ahead of the annual India-US bio-pharma summit in Boston next week.

The second wave of COVID-19 has hit India "like a tsunami", Biocon founder Kiran Mazumdar Shaw has said, attributing the unprecedented spike in coronavirus cases to the recent state elections and religious festivals in the country.

Biocon Share Price Today: On Friday, Biocon opened on the BSE at Rs 392, touching an intra day high of Rs 392 and an intra day low of Rs 380.55, in the trading session so far.

Biocon Q4 Results: Biocon's consolidated revenue increased 26 per cent in the fourth quarter of the fiscal 2020-21 to Rs 2,044 crore, compared to Rs 1,621 crore in the corresponding quarter last year.

Pharmaceutical stocks today: On Friday, Cipla opened on the NSE at Rs 840.90, touching an intra day high of Rs 892.30 and an intra day low of Rs 836.65, in the session so far

IDBI Bank's board has approved a rupee bond borrowing limit of Rs 8,000 crore for the next financial year, IDBI Bank said in a regulatory filing to the stock exchanges

Kiran Mazumdar Shaw's "Just Vaccinated" tweet added hope and cheer on Twitter today. The Executive Chairperson of Biocon, in a bid to encourage people to take the COVID-19 vaccine and wipe out fear about it, posted a chirpy pic on the microblogging site, which says "new poster on bumper - Just Vaccinated".

Biocon Biologics, an arm of biotechnology major Biocon, on Thursday said clinical study for its biologic drug Itolizumab for possible indication in autoimmune disease Lupus Nephritis has been initiated in India after approval from the Drugs C

Biocon will seek to hold a controlling majority stake in the merged entity and the companies will also look for an initial public offering (IPO).

Foreign institutional investors sold shares worth Rs 561 crore on Tuesday while domestic institutional investors bought shares worth Rs 577 crore.

The domestic stock markets are expected to trade in red on Wednesday, taking cues from the global markets.

Kiran Mazumdar-Shaw on Monday said media reports on the ''Pandora Papers'' leak have wrongly implicated her husband's offshore trust

Biocon Biologics will offer approximately 15 per cent stake to SILS, at a valuation of $4.9 billion.

Finance Minister Nirmala Sitharaman announced the formation of a 'bad bank', with the government guaranteeing up to Rs 30,600 crore for security receipts issued by the National Asset Reconstruction Company

A commentary on the website of the medical journal The Lancet authored by 21 people including Biocon's Kiran Mazumdar Shaw and top surgeon Dr Devi Shetty has recommended eight actions to prepare for a possible resurgence of COVID-19 cases in India.

The ongoing COVID-19 public health crisis has resulted in the creation of an "ecosystem" of innovation in India, Biocon chief Kiran Mazumdar-Shaw has said ahead of the annual India-US bio-pharma summit in Boston next week.

The second wave of COVID-19 has hit India "like a tsunami", Biocon founder Kiran Mazumdar Shaw has said, attributing the unprecedented spike in coronavirus cases to the recent state elections and religious festivals in the country.

Biocon Share Price Today: On Friday, Biocon opened on the BSE at Rs 392, touching an intra day high of Rs 392 and an intra day low of Rs 380.55, in the trading session so far.

Biocon Q4 Results: Biocon's consolidated revenue increased 26 per cent in the fourth quarter of the fiscal 2020-21 to Rs 2,044 crore, compared to Rs 1,621 crore in the corresponding quarter last year.

Pharmaceutical stocks today: On Friday, Cipla opened on the NSE at Rs 840.90, touching an intra day high of Rs 892.30 and an intra day low of Rs 836.65, in the session so far

IDBI Bank's board has approved a rupee bond borrowing limit of Rs 8,000 crore for the next financial year, IDBI Bank said in a regulatory filing to the stock exchanges

Kiran Mazumdar Shaw's "Just Vaccinated" tweet added hope and cheer on Twitter today. The Executive Chairperson of Biocon, in a bid to encourage people to take the COVID-19 vaccine and wipe out fear about it, posted a chirpy pic on the microblogging site, which says "new poster on bumper - Just Vaccinated".